Where does ExploraMed NC7, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ExploraMed NC7, Inc. ranks #11,644 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ExploraMed NC7, Inc. hold?

ExploraMed NC7, Inc. holds 26 US utility patents granted between 2017 and 2020, spanning 7 technology areas.

What is ExploraMed NC7, Inc.'s Innovation Score?

ExploraMed NC7, Inc. has an Innovation Score of 28.0 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ExploraMed NC7, Inc.'s patent grant rate increasing or decreasing?

ExploraMed NC7, Inc.'s recent grant velocity is -27% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ExploraMed NC7, Inc.'s patents?

ExploraMed NC7, Inc.'s patents average 12.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ExploraMed NC7, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ExploraMed NC7, Inc.

Q: What technology areas does ExploraMed NC7, Inc. focus on?

ExploraMed NC7, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 19 patents, ranking #393 of 3,490 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 26 granted patents across 7 technology areas, recorded in grant years 2017–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Exploramed ranks #11,644 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 7 technology areas.

#11,644
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.0/100): 12.0
avg claims per patent: -27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11644 · US Corporation #11,644 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,644/49,997
PHOTO-FINISH Endotronix
CPC-NARROW A61M · 7 areas
INNOV-THIN 28.0/100
CLAIMS-RICH 12.0 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -27% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Endotronix, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Exploramed’s 28.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (41%) Velocity 0.0 pts (0%) Breadth 9.4 pts (34%) Claim depth 7.2 pts (26%)

Qualcomm Incorporated · highest

85
Heizer Defense · near

28
Gazelle Semiconductor · near

28
Intellifect… · near

28
ExploraMed NC7 · this assignee

28
Clarkwestern… · near

28
3D Lighting… · lowest

7

What this shows Exploramed's Innovation Score is 28.0/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Exploramed?

Each dot is one of Exploramed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exploramed’s own 12.0 claims/patent is at or below the 18.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Exploramed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Exploramed's grants concentrate

ExploraMed NC7, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 73.1% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2020 (11 grants) versus a trough of 2 in 2017. By volume, Exploramed sits between Endotronix, Inc. and First American Financial Corporation.

Endotronix

26
Energyhub

26
Ensco Internation…

26
Estimote Polska S…

26
Extremity Medical

26
Fabbrica D'armi P…

26
Facet

26
First American Fi…

26
Exploramed NC7 ◀

26

What this shows ExploraMed holds 26 patents at rank #11,644, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ExploraMed

By rank, the assignees closest to #11,644 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in ExploraMed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ExploraMed, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), ExploraMed ranks #393 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (28 here).

Intellifect Incorporated 28 Gazelle Semiconductor, Inc. 28 Clarkwestern Dietrich Building Systems LLC 28 Heizer Defense, LLC 28

Exploramed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

ExploraMed NC7, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	7.7%
2018	6	23.1%
2019	7	26.9%
2020	11	42.3%

Which technologies does ExploraMed NC7, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 19

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 11

A61B - DIAGNOSIS; SURGERY; Identification 4

H04W - Wireless Communication Networks 1

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ExploraMed NC7, Inc.'s patent record in context - here's where to go next.

ExploraMed NC7, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 73.1% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #11,644 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ExploraMed NC7, Inc. against Endotronix, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.